Lensar (LNSR) Gains from Investment Securities (2023 - 2026)
Lensar's (LNSR) quarterly Gains from Investment Securities came in at -$23.9 million in Q1 2026, down 210.29% year-on-year from $21.7 million in Q1 2025, and down 623.5% on a QoQ basis from -$3.3 million in Q4 2025.
Lensar (LNSR) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Lensar (LNSR) has 4 years of Gains from Investment Securities data on file, last reported at -$23.9 million in Q1 2026.
- On a quarterly basis, Gains from Investment Securities fell 210.29% year-over-year to -$23.9 million in Q1 2026; TTM through Mar 2026 was -$35.3 million, a 181.0% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, down 51.69% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$23.9 million, down from -$3.3 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for LNSR reached as high as $21.7 million in Q1 2025 and fell as low as -$23.9 million in Q1 2026.
- Historically, Gains from Investment Securities has averaged $886750.0 across 4 years, with a median of -$42500.0 in 2024.
- On a YoY basis, Gains from Investment Securities climbed as much as 4486.67% in 2025 and fell as far as 1010.73% in 2025.
- Year by year, Gains from Investment Securities stood at $1.2 million in 2023, then soared by 1365.86% to $17.6 million in 2024, then slumped by 118.85% to -$3.3 million in 2025, then slumped by 623.5% to -$23.9 million in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$23.9 million in Q1 2026, -$3.3 million in Q4 2025, and -$3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.95 Mn |
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Sep 30, 2025 | -3.73 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | 21.71 Mn |
| Mar 31, 2025 | 21.71 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Sep 30, 2024 | 410,000.00 |
| Sep 30, 2024 | 410,000.00 |
| Jun 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.92 Mn |
| Mar 31, 2024 | -495,000.00 |
| Mar 31, 2024 | -495,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |